PCCP CY 2017 EQR Technical Report

Some attention has been given to the combination use of ACE-I and ARB as this may more fully block the negative effects of angiotensin II. The combination of ACE-I and ARB may be indicated for some patients. While the combination of the two medications does not improve mortality rates, they do reduce hospitalizations7. Beta blockers ................
................